Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2908 (LINC02908) is a human long non-coding RNA gene associated with the regulation of cell growth and chemotherapy resistance in cancers such as pancreatic ductal adenocarcinoma and leukemia. It is classified as a long non-coding RNA rather than a protein-coding gene, and acts as a regulatory molecule modulating microRNA activity and downstream gene expression. Although implicated in cancer biology, it is not a classical drug target such as a receptor or enzyme, but its expression and activity are of interest for cancer research and possible future interventions.
Regulates tumor biology by sponging microRNAs, e.g., miR-24-3p in acute myeloid leukemia, miR-663a in pancreatic cancer, impacting gene expression and cell growth
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2908 (LINC02908).